Análisis de la acción Humana Inc (HUM)HUMHumana Inc

Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Humana Inc is a strong buy right now due to its recent surge of 13% following an upgrade in its Medicare Advantage rating, which positions 95% of its members in plans rated 4 stars or higher. The forward P/E ratio of 24.33 indicates potential for growth, and analysts have set price targets as high as $596, suggesting significant upside from the current price of $431.87. The main risk is the recent high RSI of 75.14, indicating the stock may be overbought in the short term, but the long-term outlook remains positive.

19 analysts cover HUM: 12 rate it Buy, 7 Hold and 0 Sell. The average price target is 290.39.